Showing results (681-690 of 828) with videos related to

Sort By:
Pageof 83
Psychiatric Services (Washington, D.C.)|November 16, 2017
Testing a Web-Based, Trained-Peer Model to Build Capacity for Evidence-Based Practices in Community Mental Health SystemsRamaris E German, Abby Adler, Sarah A Frankel, et al.
Biorxiv : the Preprint Server for Biology|March 3, 2023
Development of Cell Permeable NanoBRET Probes for the Measurement of PLK1 Target Engagement in Live CellsXuan Yang, Jeffery L Smith, Michael T Beck, et al.
Journal of Neonatal-Perinatal Medicine|November 22, 2021
Management of well appearing infants born to afebrile mothers with inadequate GBS prophylaxis: A retrospective comparison of the three approaches recommended by the COFNT Beck, A J Sloane, D L Carola, et al.
Virology Journal|April 24, 2010
Identification of super-infected Aedes triseriatus mosquitoes collected as eggs from the field and partial characterization of the infecting La Crosse virusesSara M Reese, Eric C Mossel, Meaghan K Beaty, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 9, 2009
Dynamic assessment of mitoxantrone resistance and modulation of multidrug resistance by valspodar (PSC833) in multidrug resistance human cancer cellsFei Shen, Barbara J Bailey, Shaoyou Chu, et al.
Anti-Cancer Drugs|July 11, 1998
Effects of 1,2-naphthoquinones on human tumor cell growth and lack of cross-resistance with other anticancer agentsM E Dolan, B Frydman, C B Thompson, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 20, 2007
Quantitation of doxorubicin uptake, efflux, and modulation of multidrug resistance (MDR) in MDR human cancer cellsFei Shen, Shaoyou Chu, Aimee K Bence, et al.
European Archives of Psychiatry and Clinical Neuroscience|November 10, 2025
Elevated defeatist performance beliefs predict state increases in negative symptoms in daily life in clinical high-risk for psychosis youth: implications for mobile health treatmentsLauren Luther, Ian M Raugh, Luca Bela G Webber, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 9, 2007
Phase II trial of imatinib mesylate in recurrent, biomarker positive, ovarian cancer (Southwest Oncology Group Protocol S0211)D S Alberts, P Y Liu, S P Wilczynski, et al.
Journal of Neurosurgery. Case Lessons|December 18, 2023
Magnetic resonance imaging-derived relative cerebral blood volume characteristics in a case of pathologically confirmed neurocysticercosis: illustrative caseNada E Botros, David Polinger-Hyman, Ryan T Beck, et al.
Pageof 83